Publication | Open Access

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

Hematological MalignancyOncologyPrimary RefractoryPharmacologyHematologyPharmacotherapyLiposomal DaunorubicinSequential Continuous InfusionMedicineCancer ResearchMyeloid Neoplasia